SCHEMBL7943754

SCHEMBL7943754

NCc1ccc(O)c(I)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABAT P80404 1/20 0.46
ENPP2 Q13822 1/20 0.45
ADRA2A P08913 3/20 0.43
MAPK1 P28482 3/20 0.43
HIF1A Q16665 3/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
DRD2 P14416 2/20 0.43
DRD1 P21728 2/20 0.43
DRD4 P21917 2/20 0.43
DRD5 P21918 2/20 0.43
SLC6A2 P23975 2/20 0.43
DRD3 P35462 2/20 0.43
RECQL P46063 2/20 0.43
SLC6A3 Q01959 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
HTR1A P08908 2/20 0.43
ADRA1A P35348 2/20 0.43
HSD17B10 Q99714 2/20 0.43
CYP2D6 P10635 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4616776 0.83 TAAR1 (0.67) ADRA2AMAPK1HIF1AKDM4EMAPT
SCHEMBL3577593 0.82 ABAT (0.46) ABATENPP2ADRA2AMAPK1HIF1A
SCHEMBL17058723 0.81 CA1 (0.61) ADRA2AMAPK1HIF1AKDM4EMAPT
Hydrochloric Acid SCHEMBL5318190 0.81 MAPK1 (0.68) ADRA2AMAPK1HIF1AKDM4EMAPT
SCHEMBL7942390 0.79 KDM4E (0.41) ADRA2AMAPK1HIF1AKDM4EMAPT
SCHEMBL29875484 0.78 LOXL2 (0.46) ABATENPP2TAAR1GAAHRH3
SCHEMBL28879957 0.78 LOXL2 (0.46) ABATENPP2TAAR1GAAHRH3
SCHEMBL110644 0.78 KDM4E (0.67) ABATADRA2AMAPK1HIF1AKDM4E
SCHEMBL29359577 0.78 KDM4E (0.67) ABATADRA2AMAPK1HIF1AKDM4E
SCHEMBL6104943 0.77 THRB (0.40) ADRA2AMAPK1HIF1AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010054278-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2010-05-14 WO disclosed